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Abstract
Background: A significant number of individuals with high levels of aggression have substance use disorder problems. Objective: This study aimed to evaluate 
the effect of substance use disorder on aggression in young men with Antisocial personality disorder (ASPD). Methods: This cross-sectional study included 
328 patients and were diagnosed with ASPD with a comorbidity of substance use disorder, along with 111 healthy young male subjects. Results: The total 
aggression scores of the patients with a diagnosis of ASPD were significantly higher than those of the healthy group (p < 0.001). Mean scores of aggression 
subscale, except for indirect aggression, were higher in patients diagnosed with ASPD (p < 0.05). There was a positive correlation between aggression scores 
and total API scores in patients diagnosed with ASPD (p < 0.001). Aggression scores were higher when subjects were using volatile substances compared to 
other substances (p < 0.05). Aggression scores increased with duration of substance use disorder (p < 0.001). Discussion: Substance use disorder should be 
treated first to mitigate aggression in individuals with ASPD. Patients with severe addiction to volatile substances should be given treatment priority. Further 
studies are necessary to determine the cause of aggression in individuals who abuse substances. 
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Introduction
Aggression, or behavior intended to cause harm, is a common 
symptom of many psychiatric and personality disorders, particularly 
antisocial personality disorder (ASPD) – a condition that is 
significantly hard to treat due to patient- and provider-related 
difficulties1. Studies have shown that ASPD is frequently associated 
with violent behavior and abuse of alcohol and other substances2-4. 
The use of addictive substances is a global public health problem 
that leads to increased morbidity and mortality for the user, serious 
problems in the society and economic burden5. In 2015, the World 
Health Organization reported that approximately 5% of the global 
adult population had used a substance at least once and 0.6% 
suffered from substance use disorders6. Despite the adoption of 
various measures for prevention in developed countries, which have 
a higher frequency of substance abuse 6, studies show that relapses 
are frequent and adherence to treatment is poor7. According to 
the European Drug Report8, it is estimated that cannabis, the most 
commonly used substance, is used by 13.9% of young adults aged 
15-34. In young adults, substance use disorder can lead to changes 
in attitude and may provoke new behavior including violence, lying, 
stealing, damaging property, refusing to comply with rules in the 
school, home or society; they are also known to have a tendency for 
aggression, demonstrate confrontational behavior against authority 
figures and look for excuses to fight9-11. Considering these effects and 
the fact that persons with ASPD are at higher risk for substance abuse, 
the evaluation of the relationships between ASPD, substance abuse 
and aggression may increase our understanding of the conditions 
and may prove useful for the determination of risk factors.
As problems such as violent behavior and substance use disorder 
are more common among young adults and men, this study was 
planned with an aim to evaluate the effect of substance use disorder 
on aggression in young males with ASPD. 
Methods
This cross-sectional study was conducted from April 13, 2015 to 
June 30, 2016 in the psychiatry outpatient clinic of Konya Military 
Hospital. The study population consisted of ASPD patients with a 
comorbidity of substance use disorder (n = 567) and healthy young 
male volunteers (n = 210). Among these, those who met inclusion 
criteria were included in the study. A final total of 328 ASPD patients 
with substance use disorder and 111 healthy young men were 
included in the study.
The inclusion criteria for the patient group was as follows:
•  Being clinically diagnosed with ASPD according to DSM-
IV-TR diagnostic criteria, and having substance use disorder 
determined by the Turkish version12 of the SCID-II13 
according to DSM-V diagnostic criteria 5.
•  Not having any psychiatric symptoms or any other general 
condition that causes an Axis-I disorder which is associated 
with aggression (mental retardation, schizophrenia, 
schizoaffective disorder, bipolar disorder, major depression, 
post-traumatic stress disorder, intermittent explosive 
disorder, and organic psychiatric disorder) according to the 
Turkish version14 of SCID-I15.
•  Being literate and voluntarily choosing to participate in the 
study.
•  Not having an active psychotic symptom and not being under 
the influence of a substance.
•  Not meeting diagnostic criteria for mood disorder and not 
having mental disorders due to psychiatric or organic causes 
that could cause impulsivity/behavior disorder (other than 
ASPD).
•  Not being under the ongoing influence of a traumatic 
situation before the interview. 
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Healthy men that met the following criteria were included in 
the control group.
• Those without a chronic medical condition.
• Those who had never received neurological or psychiatric 
treatment.
• Those who voluntarily chose to participate in the study and 
were literate.
• Those without Axis I disorders according to SCID-I.
The research commenced after obtaining ethical approval from 
the Local Ethics Committee of Konya Military Hospital (decree 
number 2015/01/4). Before inclusion into the study, all participants 
were informed of the purpose of the research and written consent 
was obtained. 
Data collection
The demographic characteristics and other data of the patients were 
recorded during interviews. Aggression and substance abuse were 
evaluated via the Aggression Scale and Addiction Profile Index (API) 
questionnaires which were explained and applied to patients by 1 of 
3 psychiatrists who all followed a standardized procedure. Before the 
interview began, the patients were asked if they were currently under 
the influence of a substance and whether they had recently suffered 
a traumatic event. In the event that an interview did not conform to 
prior data, or the patient was considered to be under the influence of 
a substance (through examination of consciousness when necessary), 
or the patient became unresponsive, the interview was cancelled and 
scheduled with another psychiatrist at a later date.
SCID-I: A structured clinical interview scale developed by the 
American Psychiatric Association for DSM-IV Axis-I diagnoses15. 
A Turkish validity and reliability study of SCID-I was performed by 
Çorapçioglu et al.14.
SCID-II: A structured clinical interview scale developed by the 
American Psychiatric Association for DSM-III-R Axis-II diagnoses13. 
A Turkish validity and reliability study of SCID-II was performed 
by Sorias et al.16
Aggression Scale: The Aggression Scale was developed by Buss 
and Peryy (1992), updated by Buss and Waren (1992), and adapted 
to the Turkish language by Can17. The scale consists of 34 items 
which evaluate five sub-dimensions including physical aggression, 
verbal aggression, anger, hostility, and indirect aggression. The scale 
includes a five-point Likert-type rating organized as: 1 = Extremely 
uncharacteristic of me, 2 = Somewhat characteristic of me, 3 = 
Slightly characteristic of me, 4 = Completely characteristic of me, 
5 = Extremely characteristic of me. The lowest score is 34 and the 
highest score is 170. The evaluation of the scores is performed on a 
factor basis and not all scores obtained from the scale are used. A high 
score within a subscale indicates that the individual has aggressive 
behavior related to that factor.
Addiction Profile Index (API)
The API is a scale developed by Ögel et al.18 for the assessment 
of different dimensions of addiction and to determine addiction 
severity. It is a self-reported scale consisting of 37 questions and 
5 subscales which measure the characteristics of substance use, 
diagnostic criteria of addiction, the effect of substance use on 
the person’s life, the strength of desire for substance use, and the 
motivation to discontinue substance use.
Data evaluation
The SPSS 15.00 program was used for the analysis of all data obtained 
in the study. Frequency, mean, and standard deviation were used to 
assess sociodemographic data (age, socio-economic status, marital 
status and education). The Chi-square test was used to compare 
categorical data between patients and controls. Pearson’s correlation 
analysis was used to evaluate associations between aggression scale 
scores and API scores. The Independent Samples t-test was used to 
compare normally distributed continuous variables among binary 
groups, while the ANOVA or Tukey tests were used as post-hoc tests 
to compare three or more groups. The results were evaluated at the 
95% confidence interval with a 5% significance level. 
Results
The patient and control groups were similar in terms of age, marital 
status, education, and socioeconomic status (p > 0.05) (Table 1). The 
mean total aggression score (103.85 ± 31.59) of the patient group was 
found to be significantly higher than that of the healthy group (90.85 
± 21.93) (p < 0.001). When the subsections of the aggression scale 
were compared, the patient group was found to have significantly 
higher scores in all subscales except for indirect aggression (Table 2).
There was a significant positive correlation between the total API 
scores and the scores of physical aggression, verbal aggression, anger, 
hostility, and indirect aggression in patients (r = .513, r = .517, r = 
.454, r = .589, r = .537, and r = .568, respectively) (p < 0.001) (Table 3).
Total aggression score showed moderate positive correlations 
with the scores obtained from 3 of the API subsections (characteristics 
of substance use, impact of substance use on the person’s life, and 
strength of the desire for substance use) (r = .683, r = .621, and r .691, 
respectively) (p < 0.001). Additionally, total aggression scores were 
correlated positively with diagnostic criteria of addiction score and 
negatively with motivation to discontinue substance use score (r = 
.491 and r= -.393, respectively) (Table 3).
When we examined the substances used by the sample group 
and their respective mean aggression scores, a significant variance 
was observed. The Games-Howell test (based on homogeneity) was 
performed to determine which substances caused a difference in 
aggression scores; significantly higher aggression scores were noted 
with use of volatile substances compared to other substances (p < 
0.05). Synthetic cannabinoid users had significantly higher aggression 
scores than cannabis and heroin users (p < 0.05).
Out of the patients diagnosed with ASPD with a comorbidity of 
substance use disorder, those who used a single substance had a mean 
aggression score of 69.55 ± 29.67, those who used multiple substances 
had a mean aggression score of 110.47 ± 27.43. Furthermore, those 
who harmed themselves had a mean aggression score of 116.04 
± 27.00, while those who did not harm themselves had a mean 
aggression score of 82.45 ± 27.46; however, this difference was not 
statistically significant (p > 0.05). Mean aggression scores were 
significantly higher in those with intravenous drug use compared 
to those who did not use intravenous drugs (p < 0.001), and higher 
in those with legal problems compared to those without (p < 0.001). 
Finally, we also found that aggression scores increased with the 
duration of substance use disorder (p < 0.001) (Table 4).
Discussion
In the current study, young men with ASPD and a comorbid 
substance use disorder were found to have significantly higher 
aggression compared to controls, as measured by the Buss-Perry 
Aggression Scale. We also found that all subsections of the aggression 
and API scales showed significant correlations with total API score 
and total aggression score. Further analyses demonstrated that using 
synthetic cannabinoids, ecstasy and volatile substances, intravenous 
use, having a legal problem and duration of substance use were 
associated with higher aggression scores.
Our findings conform to prior studies in which substance use 
was associated with aggressive behavior19-23. In the current study, 
the patient group was found to have higher scores in anger, hostility, 
and physical and verbal aggression, while indirect aggression 
was similar with controls. In a very similar study to ours, which 
compared aggression levels in patients with substance use disorder 
and patients with comorbid ASPD and substance use disorder, it was 
97Akçay BD, Akçay D. / Arch Clin Psychiatry. 2020;47(4):95-100
Table 1. Sociodemographic comparison between patients diagnosed with ASPD with a comorbidity of substance use disorder and healthy participants
Substance use disorders (n = 328) Healthy group (n = 111) Significance*
n % n % p
Age
20 97 29.6 35 31.5 0.627
21 141 43.0 51 45.9
22 45 13.7 16 14.4
23 24 7.3 4 3.6
24 21 6.4 5 4.5
Socio-economic status
Low 107 32.6 32 28.8 0.669
Medium 188 57.3 69 62.2
High 33 10.1 10 9.0
Marital status
Married 78 23.8 20 18.0 0.446
Single 240 73.2 87 78.4
Divorced/Separated 10 3.0 4 3.6
Educational status
Primary school graduate 62 18.9 18 16.2 0.661
Secondary school graduate 212 64.6 77 69.4
High school graduate 54 16.5 16 14.4
* Chi-square test.
Table 3. Correlation between aggression scores and API scores in patients diagnosed with ASPD with a comorbidity of substance use disorder
Buss-Perry Aggression Scale Total API scores
r p*
Physical aggression 0.513 0.000
Verbal aggression 0.517 0.000
Anger 0.454 0.000
Hostility 0.589 0.000
Indirect aggression 0.537 0.000
Buss-Perry Aggression Scale Total aggression scores
r p*
Substance use disorder characteristics 0.683 0.000
Diagnosis 0.491 0.000
Impact on life 0.621 0.000
Strong urge 0.691 0.000
Motivation -0.393 0.000
Total API scores 0.568 0.000
* Significant correlation at 0.001. 
Table 2. Aggression status comparison between patients diagnosed with ASPD with a comorbidity of substance use disorder and healthy participants
Buss-Perry Aggression Scale Substance use disorders (n = 
328)
Healthy group (n = 111) Significance*
xx ± ss xx ± ss F p
Physical aggression 26.42 ± 10.73 22.05 ± 6.37 94.178 0.000
Verbal aggression 15.52 ± 5.13 14.44 ± 4.22 10.114 0.002
Anger 24.63 ± 6.72 21.07 ± 5.52 7.447 0.007
Hostility 22.45 ± 6.59 18.04 ± 5.15 6.160 0.013
Indirect aggression 14.84 ± 5.30 15.24 ± 4.82 3.353 0.068
Total aggression score 103.85 ± 31.59 90.85 ± 21.93 34.064 0.000
* T-test in independent groups.
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found that patients with the comorbid condition were significantly 
more aggressive than those with only substance abuse24. This finding 
is supported by the fact that both conditions elevate impulsivity 
and decrease inhibitory control25,26, suggesting that ASPD and 
substance abuse both contribute to the aggression of patients. A 
study by Sökmen et al., which was performed on adolescents with 
substance addiction, reported that physical aggression and hostility 
scores were higher among adolescents with addiction, while verbal 
aggression, anger, and indirect aggression scores were surprisingly 
lower, revealing a contrast to our study11. However, all of our patients 
had comorbid ASPD and substance abuse, therefore the aggressive 
characteristics of our patients would be expected to be higher than 
those without ASPD. Furthermore, Hyde et al. reported that antisocial 
behavior during the adolescence was associated with a higher risk 
of ASPD diagnosis in adulthood27, which may show that earlier 
substance abuse that causes aggression and/or antisocial behavior 
may transform to ASPD later on in life, further increasing aggression. 
In agreement with this hypothesis, comorbid ASPD and substance 
abuse has been reported to be associated with predisposition to 
aggressive behavior28,29. The key point in this association may be 
the fact that ASPD patients and those with substance abuse have 
similar characteristics in terms of seeking stimulus, suggesting a bi-
directional relationship between the conditions and therefore leading 
to the age old question “which comes first?”. Although the literature is 
limited in this aspect, it may be reasonable to suggest that the search 
for stimulus may be the initial reason that adolescents succumb to 
drug use, leading to antisocial/violent behavior and finally forming 
a vicious cycle embodied by ASPD. However, this train of thought 
is in no way the only explanation of the relationship between the 
conditions and requires confirmation. Therefore, we believe that 
treating stimulus seeking behavior before starting direct therapy 
for substance abuse may increase the likelihood of positive clinical 
outcome. Although the overwhelming majority of studies in this 
field demonstrate that ASPD and substance abuse both contribute 
to aggression, contrasting findings also exist. For instance, a study 
by Shorey et al. showed that aggressive behavior was not associated 
with alcohol or substance abuse in patients with ASPD30.
The fact that indirect aggression was not significantly increased 
in the patient group may be associated with the features of indirect 
aggression itself. Indirect aggression requires more advanced 
cognitive skills compared to other forms of aggression31,32. The 
similarity between indirect aggression behavior score of the groups 
may be attributed to the fact that the majority of the study group was 
comprised of males with low education levels, while the impairment 
of social-cognitive abilities among those with substance use disorders 
may also be another explanation to the lack of difference.
Ekinci et al.33 found that the scores obtained in subsections of the 
API, such as the effect of substance use on the person’s life, the desire 
for substance use, and the motivation to discontinue substance use, 
were higher among those with higher aggression scores. The same 
study stated that, with increased anger levels, the impact of substance 
use disorder on the person’s life increases, along with the desire to 
use the substance. However, Kaplan et al. reported no statistically 
significant relationship between aggression level and API, among 
children living in the streets34. Contrastingly, the current study 
found that aggression scores were significantly correlated with API. 
When examining the correlations between total aggression scores 
and the API subscales, it can be seen that motivation to discontinue 
substance use decreases as aggression scores increase. It is assumed 
that the level of aggression increases when motivation to discontinue 
substance use decreases, caused by the inability to decide to make a 
change or not, a situation with which they cannot cope. Therefore, 
close follow-up and supportive conduct during treatment may be 
beneficial for patients with high motivation to discontinue drug use.
In the current study, the type of substance was found to be 
a significant contributor to aggression scores. Those who used 
synthetic cannabinoids, ecstasy and volatile substances were found 
to have higher mean total aggression scores. A large meta-analysis 
study reported cocaine was the substance with the strongest link to 
psychological, physical, and sexual aggression. Cannabis was also 
associated with aggression towards a partner35. Other studies also 
reported higher aggression scores among those who used volatile 
substances 36. Although earlier studies have associated cannabis with 
Table 4. Comparison of aggression scores of patients diagnosed with ASPD with a comorbidity of substance use disorder with certain descriptive information
Total aggression score Significance*
n (%) xx ± ss F p
Most frequently used substance 11.171 0.000**
Cannabis 158 (48.2) 95.80 ± 32.42
Heroin 79 (24.1) 100.53 ± 28.89
Synthetic cannabinoid 56 (17.1) 119.64 ± 28.93
Pill (Ecstasy) 20 (6.1) 115.10 ± 22.40
Volatile substance (Thinner, Bally) 15 (4.6) 132.20 ± 8.08
Substance use disorder characteristics
Single substance use disorder 53 (16.2) 69.55 ± 29.67 0.483 0.487*
Multiple substance use disorder 275 (83.8) 110.47 ± 27.43
Intravenous substance use disorder status
Yes 41 (12.5) 117.44 ± 23.04 13.145 0.000*
No 287 (87.5) 101.91 ± 32.19
Legal problem status
Yes 161 (49.1) 111.92 ± 27.53 17.277 0.000*
No 167 (50.9) 96.08 ± 33.33
Self-harm 
Yes 209 (63.7) 116.04 ± 27.00 0.470 0.494*
No 119 (36.3) 82.45 ± 27.46
Duration of substance use disorder
0-1 year 38 (11.6) 81.03 ± 33.35 24.259 0.000**
2-5 year 199 (60.7) 101.23 ± 30.96
6-12 year 91 (27.7) 119.12 ± 24.81
* T-test in independent groups. ** Analysis of variance.
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increased aggression37, our findings show that the control group and 
cannabis users had comparable total aggression scores (90.85 ± 6.37 
vs. 95.80 ± 32.42). However, the variance in scores among those 
using cannabis demonstrate that the effects of cannabis cannot be 
considered uniform among all users. 
Similar to the study by Kaplan, the aggression level of patients 
were found to increase with longer duration of substance use 
in our study group, and the aggression scores of those who had 
legal problems were significantly higher than those who had no 
legal problems34. As these substances weaken inhibitory control 
mechanisms and lead to higher activity, individuals are prone to 
exerting more aggressive and uncontrolled behaviors20. Substance use 
disorder encourages individuals to disobey rules and exert destructive 
behaviors such as harming themselves and the environment, 
increasing their tendency to commit crimes.
Violent acts and aggressive behavior in patients with substance 
abuse may also be associated to the fact that users commit crimes 
to acquire money for access to the substance20. This possibility is 
an important contributor to the high level of aggression among 
the young men that participated in this study. One of the study 
limitations is that the majority of patients were soldiers who were 
aged between 20-25 years; therefore, the findings can be generalized 
only for young males aged 20 to 25 years of age. Similar studies with 
larger sample sizes are needed to obtained more conclusive results. 
Our findings suggest that substance use disorder is mediated by 
aggression. Therefore, aggression is an important factor that should 
be evaluated in the treatment of substance addiction. Particularly 
in the intervention studies to be conducted, those with high 
addiction severity and patients who use volatile substances should 
be considered as the priority treatment group. Further studies are 
necessary to determine the causes of aggression in substance use 
disorders and to evaluate the relationships between ASPD and 
substance abuse.
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